Vitasora says its remote-care model is now functioning, with estimated September-quarter revenue of US$1.028 million and a September exit rate of about US$17,400 a day. The next test is execution: turning planned Care Coordinator hiring into sustained, reconciled revenue and operational break-even.
- US$1.028 million estimated September-quarter revenue, up 38% on June
- 32 productive Care Coordinators at September exit, with 115 targeted by Q1 2027
- September exit activity estimated at US$17,400 a day, including assumed RPM revenue
- Care minutes rose 44% to 339,000 in the September quarter
- Operational break-even measure excludes Australian corporate costs and the UPEC contract shortfall
September Revenue Estimate Reaches US$1.028 Million
Vitasora Health Limited (ASX:VHL; OTCQB:VHLUF) is betting that its next growth constraint is no longer software or patient demand, but the number of productive people delivering care. The company’s estimated September-quarter revenue reached US$1.028 million, 38% above the June quarter, while an illustrative September exit rate climbed to about US$17,400 a day.
Those figures are not reported accounting revenue. They are unaudited management estimates built from care-activity records, the USA management profit and loss account and other management records, and remain subject to reconciliation. The exit rate is also explicitly illustrative rather than a forecast, with the daily figure including an assumed US$2,000 of remote patient monitoring revenue.
vCare and Workflow Changes Lift Capacity
The operating metrics nevertheless show a marked improvement in activity. CCM-program care minutes rose 44% year on year to 339,000 in the September quarter, while all-care-type minutes reached 10,516 a day at the late-September exit. Vitasora said utilisation was 88.5% at that exit across all care types, moving toward its 95% objective.
The figures represent the early operating effect of the vCare platform rollout, which was launched in April. Vitasora says the EMR-integrated platform and workflow redesign allow qualified Care Coordinators to be allocated more flexibly across clients and patients. It reported that 75% of new coordinators reached full utilisation within two weeks, although the underlying operating data remain unaudited.
Hiring Plan Puts the Break-Even Claim to the Test
Vitasora had 32 productive Care Coordinators and 39 employees including those in training at the end of September. It plans to reach 48 employed coordinators by late in the fourth quarter of 2026 and is targeting 115 productive coordinators by the first quarter of 2027. Management’s capacity scenarios imply that additional productive staff can translate into more care minutes, billing codes and revenue, but those scenarios depend on hiring, training and utilisation assumptions.
Patient activity is also moving in the company’s preferred direction. September enrolment activity was 796, taking the quarter to 1,596, while a September run-rate would imply 2,388 enrolments per quarter. Vitasora says that activity came from existing clients’ patient populations, with new client contracts expected to provide additional populations. Its estimate of 2.13 care CPTs per qualifying patient in the September quarter was above the original planning assumption of roughly two, with RPM activity providing another revenue stream.
Clinical Data Offers Support but Not Proof
The update also presented observational data from one partner primary-care practice. Among 435 patients, 303 finished below the stated 140/90 blood-pressure threshold, while average systolic pressure fell by 8.5 points across the periods shown. The company linked stronger engagement with better results, but the analysis had no comparison group and did not capture medication changes. Its references to lower stroke and major-heart-event risk were modelled from published research, not measured outcomes from this cohort.
Vitasora defines operational break-even as estimated revenue plus UPEC revenue covering US operating costs, excluding the UPEC contract shortfall and Australian group corporate costs. That narrower measure is important: reaching it would not necessarily mean the group as a whole had achieved cash-flow break-even. The next evidence will need to come from reconciled revenue, cash receipts, operating costs and whether the higher activity level can be sustained for a full month.
Bottom Line?
Vitasora has shown stronger operating momentum, but the investment case now rests on making planned capacity productive while converting management estimates into audited revenue and broader break-even progress.
Questions in the middle?
- Can Vitasora recruit and make 48, then 115, Care Coordinators productive within its stated timetable?
- Will the September activity and exit-rate estimates reconcile with reported revenue and cash receipts?
- Can the company sustain operational break-even after including the UPEC shortfall and Australian corporate costs?